Home › Non-Hodgkin Lymphoma › District of Columbia › Washington

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Washington, DC

Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

American Oncology Partners of Maryland Pa, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Nagre-recruitPhase 1/2

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05442515

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Nagre-recruitPhase 3

GC2202 Study Site 111, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05645107

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Nagre-recruitPhase 1/2

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03223610

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Nagre-recruitObservasyonal na pag-aaral

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02682667

Tissue Collection for Studies of Lymph Cancer

Nagre-recruitObservasyonal na pag-aaral

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01676805

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Nagre-recruitPhase 2

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05907759

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01087333

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04002947

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

Nagre-recruitObservasyonal na pag-aaral

Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo

Edad 4 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07652580

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Medstar Georgetown University Hospital, Washington D.C.

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

Children's National Medical Center, Washington D.C.

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Nagre-recruitPhase 1

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05389423

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Nagre-recruitPhase 3

American Oncology Partners of Maryland, PA, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

MedStar Georgetown University Hospital, Washington D.C.

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Children's National Medical Center, Washington D.C.
Nih/Niaid, Bethesda · 7 mi ang layo
Nih/Nhlbi, Bethesda · 7 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Nagre-recruitPhase 1/2

The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT04068597

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Silver Spring · 7 mi ang layo
Massive Bio SYNERGY-AI site, Bethesda · 7 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Washington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.